Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Metabiota

Explore full profile

Delivering actionable, data-driven insights that help organizations manage infectious disease risk

San Francisco, United StatesFounded 2008Biotech & Life Sciences
Valuation $100–500M Latest valuation · 2015
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Metabiota and the history behind them.

About Metabiota

Metabiota is a San Francisco-based company with over a decade of experience in helping industries and governments worldwide prepare for and manage epidemic risks. With additional offices in Washington DC, Cameroon, and the Democratic Republic of the Congo, Metabiota operates on a global scale. The company specializes in providing data, analytics, advice, and training to support decision-makers in making informed, data-driven choices to protect public health and ensure global health security.

Read full description

Metabiota serves a diverse range of clients, including corporate entities, insurance companies, government agencies, and multilateral organizations. The company operates in the public health and epidemic risk management market, focusing on estimating, mitigating, and managing the risks associated with epidemics. This is crucial as epidemics can have devastating impacts on both lives and economies.

The business model of Metabiota revolves around offering a suite of services that include data collection and analysis, risk assessment, and strategic advisory. They also provide training programs to help organizations build resilience against potential health threats. By leveraging their expertise in various scientific disciplines such as epidemiology, veterinary medicine, laboratory science, data science, actuarial science, social science, and political economics, Metabiota delivers comprehensive solutions to its clients.

Metabiota generates revenue through the sale of its data and analytics services, consulting fees, and training programs. The company has been recognized for its innovative solutions, winning several awards such as Catastrophe Risk Modelling Solution of the Year 2020 and Insurtech Impact 25 in 2019.

In summary, Metabiota is a key player in the field of epidemic risk management, providing essential tools and insights to help organizations worldwide prepare for and mitigate the impacts of global health threats.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
San Francisco, United States
Employees
83
Open positions
None listed
Dealroom signal
58.3/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Supply Chain Management, Risk Management, Analytics, Biotechnology, Biotech and Pharma, Parametric Insurance, Hard Tech, DT and LS, science-based
Business model
SaaS
Client focus
b2b
Investment activity
1 company, latest Jun 2016
Capital deployed
$8.9M
Preferred round
SERIES A

Latest news

Press, funding announcements and product moves mentioning Metabiota.

See all news

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCEquity / VC Jun 2026 $0 Undisclosed
SERIES BEquity / VC Dec 2018 $0 In-Q-Tel
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Metabiota website traffic

Latest recorded traffic for Metabiota is 1.5K monthly website visits, down 50% over the last three months. Metabiota's team grew 0% over the past year.

Latest monthly visits1.5K 3-month web change-50% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

22 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed10 investors entered at this stage

  • Pilot Growth Equity
  • Tim O'Reilly
  • DCVC
  • Georges Harik
  • Tao Capital Partners
  • Stephen Luczo
  • Adrian Aoun
  • Undercurrent
  • James Joaquin
  • SciFi VC

Series A9 investors entered at this stage

Other known investors3 additional known investors

  • GV
  • Lloyd's lab
  • Technology Pioneers | World Economic Forum
Team profiled 24 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Metabiota on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Metabiota’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.